DU Chunyan, WANG Chunhui. Effects of different probiotics on the balance of intestinal flora in neonatal antibiotic-associated diarrhea[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 34-36,40. DOI: 10.7619/jcmp.202019010
Citation: DU Chunyan, WANG Chunhui. Effects of different probiotics on the balance of intestinal flora in neonatal antibiotic-associated diarrhea[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 34-36,40. DOI: 10.7619/jcmp.202019010

Effects of different probiotics on the balance of intestinal flora in neonatal antibiotic-associated diarrhea

More Information
  • Received Date: August 20, 2020
  • Objective To investigate the effects of different probiotics on intestinal flora, serum tumor necrosis factor-alpha(TNF-α)and interleukin-6(IL-6)in neonatal antibiotic-associated diarrhea. Methods A total of 78 children with antibiotic-related diarrhea were randomly divided into observation group and control group, with 39 cases in each group. The control group took Saccharomyces boulardii, and the observation group took Combined Clostridium Butyricum and Bifidobacterium Powders. The diarrhea situation and clinical efficacy were compared between the two groups, and the changes of number of intestinal flora as well as serum TNF-α and IL-6 level before and after treatment were compared. Results There was no significant difference between the two groups in the time from antibiotics to diarrhea(P>0.05). The duration of stopping diarrhea and hospitalization time in the observation group were significantly shorter than those in the control group(P<0.05). After 3 days of treatment, the number of bifidobacteria, eubacteriums and lactobacillus in feces of the two groups was significantly higher than those before treatment, while the number of bifidobacteria, eubacteriums and lactobacillus in the observation group was significantly higher than those in the control group(P<0.05); the serum TNF-α and IL-6 levels were significantly lower in the observation group than those in the control group(P<0.05). The total clinical effective rate of the observation group was 89.74%, which was significantly higher than 69.23% of the control group(P<0.05). Conclusion The treatment of antibiotic-associated diarrhea and Combined Clostridium Butyricum and Bifidobacterium Powders can effectively shorten the diarrhea and hospital stay in children, significantly increase the number - of intestinal flora and reduce inflammatory response.
  • 杨璐颖, 阮晓宇, 王灵芝. 益生菌联合早期微量喂养对早产儿肠道菌群及免疫功能影响的相关性研究[J]. 中国微生态学杂志, 2019, 31(6): 694-698.
    张雪梅, 袁振亚, 乔嘉凯, 等. 肠道菌群与抗生素相关性腹泻的关系[J]. 微生物学通报, 2019, 46(9): 2386-2393.
    陈思敏, 毛杰, 陈志茹. 益生菌联合水溶性膳食纤维对老年抗生素相关性腹泻的防治效果[J]. 天津医药, 2018, 46(3): 284-287.
    陈求凝, 张雪梅, 谢邦贵, 等. 不同抗菌药物对肺部感染新生儿肠道菌群及消化系统影响的研究[J]. 中华医院感染学杂志, 2018, 28(16): 2531-2534.
    贺晓兰, 马辰莺, 徐晓婷. 肠道菌群在恶性肿瘤治疗中的研究进展[J]. 中华放射医学与防护杂志, 2019, 39(6): 476-480.
    马科, 寇艳, 卢蓉, 等. 匹多莫德对抗生素相关性腹泻患儿的免疫功能及炎症反应的影响[J]. 现代生物医学进展, 2018, 18(24): 4786-4789.
    彭双勤. 益生菌类药物联合蒙脱石散对小儿腹泻血清学免疫指标的影响[J]. 山西医药杂志, 2018, 47(11): 1237-1239.
    丁姮月, 孙宏文. 肠道菌群与腹泻型肠易激综合征相关性的研究进展[J]. 中国微生态学杂志, 2019, 31(1): 119-125.
    刘跃平, 石涵, 李红, 等. 益生菌对病毒性腹泻患者菌群结构及黏膜屏障功能变化的影响[J]. 中国预防医学杂志, 2018, 19(6): 448-451.
    蒋国丞, 蒋瑾, 杨拾梅. 匹多莫德对抗生素相关性腹泻患儿免疫球蛋白、T细胞亚群及炎症因子的影响[J]. 实用药物与临床, 2018, 21(5): 557-560.
    陈雪. 益生菌对新生儿肺炎继发性腹泻的防治效果及其对胃肠功能的影响[J]. 实用心脑肺血管病杂志, 2018, 26(2): 118-120.
    黄清梅, 陆斯良, 陈玉君, 等. β-内酰胺类抗生素及益生菌干预对晚期早产儿肠道菌群的影响[J]. 广西医科大学学报, 2018, 35(5): 664-667.
    臧凯丽, 江岩, 孙勇, 等. 微生态制剂调节便秘、腹泻人群肠道菌群结构与产短链脂肪酸关键菌属的相关性[J]. 食品科学, 2018, 39(5): 155-165.
    陈玥, 王秀英, 刘磊. 临床药师对抗生素相关性腹泻干预的效果分析[J]. 临床药物治疗杂志, 2018, 16(6): 75-77.
    高达, 孙颖, 姜瞻梅, 等. 益生菌调节由抗生素导致肠道菌群失衡的研究进展[J]. 中国乳品工业, 2019, 47(2): 30-33

    , 47.
    田恬, 景芳丽, 高小倩. 醒脾养儿颗粒辅助治疗婴幼儿抗生素相关性腹泻临床研究[J]. 陕西中医, 2018, 39(8): 1112-1114.
    徐雯, 谢永武, 段丽. 双歧杆菌四联活菌片治疗儿童抗生素相关性腹泻的疗效及对患儿免疫功能的影响[J]. 海南医学, 2019, 30(6): 753-755.
    冯爱民, 杨惠侠. 不同益生菌对抗生素相关性腹泻肺炎新生儿肠道菌群及促炎因子的影响[J]. 中国微生态学杂志, 2019, 31(7): 808-811

    , 815.
  • Related Articles

    [1]MENG Lijun, ZHANG Lanfang, QIN Lei, LI Wenjing, SHEN Peijun, CHEN Xu, GUO Xiaohe. Values of serum tumor necrosis factor-α stimulated gene 6 protein and type ⅩⅥ collagen in predicting prognosis of patients with ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 87-90, 95. DOI: 10.7619/jcmp.20243615
    [2]ZHANG Xiaohui. Efficacy of mesalazine alone and live bifidobacterium in combination on the treatment of ulcerative colitis and their effects on TNF-α, IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2018, (3): 112-114. DOI: 10.7619/jcmp.201803032
    [3]WEI Xuefei, XU Pei, CHEN Zairong, GUO Wanhua. Expressions and significance of serum IFN-γ,IL-4, IL-6 and IL-10 in treatment of patients with renal cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (7): 68-70. DOI: 10.7619/jcmp.201507019
    [4]ZHANG Hu, LI Zhi. Effect of Astragalus injection on serum tumor necrosis factor-α, interleukin-6 and angiotensin Ⅱ in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (23): 17-19. DOI: 10.7619/jcmp.201423006
    [5]ZHANG Mingsen, WANG Bin, SUN Yang. Effects of different intravascular volume expansion solutions on serum levels of TNF-α and IL-6 in perioperative patients with craniocerebral trauma[J]. Journal of Clinical Medicine in Practice, 2014, (21): 52-54. DOI: 10.7619/jcmp.201421015
    [6]QIU Zhenqin, DU Zhongde, XU Jiagang. Influence of Danhong injection on the level of serum interleukin-6 and Interleukin-10 in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (19): 17-19. DOI: 10.7619/jcmp.201419006
    [7]BAI Yun, QIU Chuxiong, XUE Weixin, LIN Feng, HUANG Shouyuan, NING Liangzhong, ZHANG Chenghao, YAO Yongzhi. Clinical efficacy of Shenkang Injection and its influence on C-reactive protein and interleukin-6 levels in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2014, (15): 17-19. DOI: 10.7619/jcmp.201415006
    [8]WU Yiping. Clinical significance of serum tumor necrosis factor-α and interleukin-6 in measuring acute intussusception in the infants[J]. Journal of Clinical Medicine in Practice, 2013, (24): 75-77. DOI: 10.7619/jcmp.201324022
    [9]MO Liya, WU Yonghua, WANG Minhong. Association of IL-6, TNF-α and clinical stages,ventilation function in elderly patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (19): 4-6. DOI: 10.7619/jcmp.201319002
    [10]SUN Changjiang, FAN Hui, GE Jianbin. Effect of Xuebijing injection on serum concentrations of TNF-α, IL-1β and IL-6in patients with acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2013, (9): 83-85,90. DOI: 10.7619/jcmp.201309029
  • Cited by

    Periodical cited type(15)

    1. 马治娥,赵文娟,王沛. 不同质子泵抑制剂对胃溃疡患者胃肠激素及氧化应激的影响. 贵州医药. 2024(01): 55-56 .
    2. 孙敏. 四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析. 中国校医. 2024(01): 61-64 .
    3. 黄莉莉,黄晶晶. 奥美拉唑联合纤维蛋白粘合剂在消化性溃疡出血中的应用效果分析. 中国烧伤创疡杂志. 2024(03): 240-244 .
    4. 王燕,宋建国,李红,温爽,付琳璐. 雷尼替丁联合消化内镜对十二指肠溃疡的治疗效果. 中国医药指南. 2024(16): 86-89 .
    5. 刘雅红. 单用质子泵抑制剂治疗消化性溃疡对根除幽门螺杆菌的影响. 中国现代药物应用. 2024(14): 112-114 .
    6. 白玲,赵琴. 血清谷胱甘肽过氧化物酶、脂质过氧化物水平与妊娠期糖尿病及其糖脂代谢异常、胰岛素抵抗和母婴结局的关系. 安徽医药. 2024(11): 2226-2230 .
    7. 陈偲. 小组式知信行健康宣教在消化道溃疡患者中的应用. 江苏卫生事业管理. 2024(10): 1420-1422 .
    8. 王建东. 愈疡健脾方联合质子泵抑制剂治疗脾胃虚寒型消化性溃疡的临床观察. 基层医学论坛. 2024(36): 153-156 .
    9. 陈波,张庆团,黄克锋,杨燕芬,熊弋平. 瑞巴派特四联疗法对幽门螺杆菌阳性消化性溃疡患者血清氧化应激指标和胃蛋白酶原的影响. 现代生物医学进展. 2023(11): 2168-2172 .
    10. 黄小花. 健胃愈疡汤辅助四联疗法治疗十二指肠溃疡的效果及对溃疡面积、胃肠相关指标的影响. 临床合理用药. 2023(29): 81-84 .
    11. 俞洪韵,陈慧丽,朱锋,汪璇,陶治华. 健胃愈疡颗粒联合西咪替丁治疗重症患者应激性溃疡的临床研究. 现代药物与临床. 2023(10): 2506-2510 .
    12. 胡量. 康复新液治疗胃溃疡的临床疗效及对炎性因子、氧化应激和胃黏膜修复作用的影响分析. 现代诊断与治疗. 2023(17): 2543-2545+2556 .
    13. 陆文鹏,陈民,陈洁,郑新梅,董小耘. 基于生物信息学探讨败酱散调控氧化应激缓解克罗恩病的机制. 实用临床医药杂志. 2022(16): 11-17 . 本站查看
    14. 黄以治. 胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果. 中国医药指南. 2022(35): 29-32 .
    15. 张珊珊,刘畅,阴雨龙. 奥美拉唑与雷尼替丁治疗十二指肠溃疡的疗效对比分析. 中外医疗. 2022(31): 136-139 .

    Other cited types(3)

Catalog

    Article views (646) PDF downloads (13) Cited by(18)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return